| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | -0.064 | 0.2 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | rTRAIL | GDSC1000 | pan-cancer | AAC | 0.044 | 0.2 |